InhaleRx Statistics

Total Valuation

InhaleRx has a market cap or net worth of AUD 5.34 million. The enterprise value is 5.18 million.

Market Cap	5.34M
Enterprise Value	5.18M

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

InhaleRx has 213.45 million shares outstanding. The number of shares has increased by 12.72% in one year.

Current Share Class	213.45M
Shares Outstanding	213.45M
Shares Change (YoY)	+12.72%
Shares Change (QoQ)	+24.96%
Owned by Insiders (%)	29.53%
Owned by Institutions (%)	1.03%
Float	74.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.28
PB Ratio	-83.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.28
EV / Sales	12.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.92

Current Ratio	0.92
Quick Ratio	0.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.55

Financial Efficiency

Return on equity (ROE) is -402.12% and return on invested capital (ROIC) is -133.73%.

Return on Equity (ROE)	-402.12%
Return on Assets (ROA)	-69.85%
Return on Invested Capital (ROIC)	-133.73%
Return on Capital Employed (ROCE)	2,010.08%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.35
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.50% in the last 52 weeks. The beta is -0.08, so InhaleRx's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-37.50%
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	53.50
Average Volume (20 Days)	46,493

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InhaleRx had revenue of AUD 401,811 and -1.21 million in losses. Loss per share was -0.01.

Revenue	401,811
Gross Profit	401,811
Operating Income	-1.28M
Pretax Income	-1.21M
Net Income	-1.21M
EBITDA	n/a
EBIT	-1.28M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 194,915 in cash and 34,062 in debt, giving a net cash position of 160,853 or 0.00 per share.

Cash & Cash Equivalents	194,915
Total Debt	34,062
Net Cash	160,853
Net Cash Per Share	0.00
Equity (Book Value)	-63,966
Book Value Per Share	-0.00
Working Capital	-63,645

Full Balance Sheet

Cash Flow

Operating Cash Flow	-368,767
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-318.39%
Pretax Margin	-300.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

InhaleRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.72%
Shareholder Yield	-12.72%
Earnings Yield	-22.66%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

InhaleRx has an Altman Z-Score of -28.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28.74
Piotroski F-Score	n/a